Hematoporphyrin dihydrochlordie
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 329601

CAS#: 17696-69-4 (HCl)

Description: Hematoporphyrin, also known as Photodyn, Sensibion, is an endogenous porphyrin formed by the acid hydrolysis of hemoglobin. Nencki and Zaleski determined its chemical structure in 1900. Hematoporphyrin has been used as an antidepressant and antipsychotic since the 1920s.


Chemical Structure

img
Hematoporphyrin dihydrochlordie
CAS# 17696-69-4 (HCl)

Theoretical Analysis

MedKoo Cat#: 329601
Name: Hematoporphyrin dihydrochlordie
CAS#: 17696-69-4 (HCl)
Chemical Formula: C34H40Cl2N4O6
Exact Mass: 0.00
Molecular Weight: 671.616
Elemental Analysis: C, 60.80; H, 6.00; Cl, 10.56; N, 8.34; O, 14.29

Price and Availability

Size Price Availability Quantity
100mg USD 250 2 Weeks
250mg USD 485 2 Weeks
500mg USD 850 2 Weeks
Bulk inquiry

Related CAS #: 17696-69-4 (2HCl)   6033-50-7 (HCl)   14459-29-1 (free base)    

Synonym: Hematoporphyrin HCl; Hematoporphyrin dihydrochloride; Hematoporphyrin HCl; Hematoporphyrin IX dihydrochloride; Photodyn, Sensibion.

IUPAC/Chemical Name: 21H,23H-Porphine-2,18-dipropanoic acid, 7,12-bis(1-hydroxyethyl)-3,8,13,17-tetramethyl-, dihydrochloride

InChi Key: QCLJGYHFHNRFIL-UDHHKLSBSA-N

InChi Code: InChI=1S/C34H38N4O6.2ClH/c1-15-21(7-9-31(41)42)27-14-28-22(8-10-32(43)44)16(2)24(36-28)12-29-34(20(6)40)18(4)26(38-29)13-30-33(19(5)39)17(3)25(37-30)11-23(15)35-27;;/h11-14,19-20,36-37,39-40H,7-10H2,1-6H3,(H,41,42)(H,43,44);2*1H/b23-11-,24-12-,25-11-,26-13-,27-14-,28-14-,29-12-,30-13-;;

SMILES Code: O=C(O)CCC1=C2/C=C3C(CCC(O)=O)=C(C)C(/C=C(N/4)/C(C)=C(C(O)C)C4=C\C5=N/C(C(C(O)C)=C5C)=C\C(N2)=C1C)=N/3.[H]Cl.[H]Cl

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 671.62 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Pu Y, Chen W, Yu Z. Research progress of Hemoporfin--part one: preclinical study. Photodiagnosis Photodyn Ther. 2012 Jun;9(2):180-5. doi: 10.1016/j.pdpdt.2011.09.004. Review. PubMed PMID: 22594989.

2: Batinic-Haberle I, Rajic Z, Tovmasyan A, Reboucas JS, Ye X, Leong KW, Dewhirst MW, Vujaskovic Z, Benov L, Spasojevic I. Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics. Free Radic Biol Med. 2011 Sep 1;51(5):1035-53. doi: 10.1016/j.freeradbiomed.2011.04.046. Review. PubMed PMID: 21616142; PubMed Central PMCID: PMC3178885.

3: Kuroki M, Hachimine K, Abe H, Shibaguchi H, Kuroki M, Maekawa S, Yanagisawa J, Kinugasa T, Tanaka T, Yamashita Y. Sonodynamic therapy of cancer using novel sonosensitizers. Anticancer Res. 2007 Nov-Dec;27(6A):3673-7. Review. PubMed PMID: 17970027.

4: Schmutz JL. [Squamous cell carcinoma following photodynamic therapy]. Ann Dermatol Venereol. 2015 Jun-Jul;142(6-7):463-4. doi: 10.1016/j.annder.2015.02.002. Review. French. PubMed PMID: 25863920.

5: Nagy EM, Dalla Via L, Ronconi L, Fregona D. Recent advances in PUVA photochemotherapy and PDT for the treatment of cancer. Curr Pharm Des. 2010 Jun;16(16):1863-76. Review. PubMed PMID: 20337576.

6: Polo L, Valduga G, Jori G, Reddi E. Low-density lipoprotein receptors in the uptake of tumour photosensitizers by human and rat transformed fibroblasts. Int J Biochem Cell Biol. 2002 Jan;34(1):10-23. Review. PubMed PMID: 11733181.

7: Ortner MA. Photodynamic therapy for cholangiocarcinoma: overview and new developments. Curr Opin Gastroenterol. 2009 Sep;25(5):472-6. doi: 10.1097/MOG.0b013e32832e6e1f. Review. PubMed PMID: 19550314.

8: Chakraborti AS. Interaction of porphyrins with heme proteins--a brief review. Mol Cell Biochem. 2003 Nov;253(1-2):49-54. Review. PubMed PMID: 14619955.

9: Quirk BJ, Brandal G, Donlon S, Vera JC, Mang TS, Foy AB, Lew SM, Girotti AW, Jogal S, LaViolette PS, Connelly JM, Whelan HT. Photodynamic therapy (PDT) for malignant brain tumors--where do we stand? Photodiagnosis Photodyn Ther. 2015 Sep;12(3):530-44. doi: 10.1016/j.pdpdt.2015.04.009. Review. PubMed PMID: 25960361.

10: Zawirska B. [New methods of locating and treating malignant neoplasms by using a hematoporphyrin derivative and photoradiation]. Postepy Hig Med Dosw. 1987 Nov-Dec;41(6):579-96. Review. Polish. PubMed PMID: 2967470.

11: Stanowski E, Graczyk A, Konarski J, Sobczyńska J. [Mechanism of action and clinical use of photoactivated hematoporphyrins in oncology]. Pol Tyg Lek. 1986 Jun 9;41(23):758-65. Review. Polish. PubMed PMID: 2945169.

12: Salet C. Hematoporphyrin and hematoporphyrin-derivative photosensitization of mitochondria. Biochimie. 1986 Jun;68(6):865-8. Review. PubMed PMID: 3019436.

13: Abramson AL, Waner M, Brandsma J. The clinical treatment of laryngeal papillomas with hematoporphyrin therapy. Arch Otolaryngol Head Neck Surg. 1988 Jul;114(7):795-800. Review. PubMed PMID: 2838053.

14: Guillemin F, Cosserat-Gérardin I, Notter D, Vigneron C. [Diagnosis and treatment of bladder tumors by photodynamic therapy]. Pathol Biol (Paris). 2001 Dec;49(10):815-23. Review. French. PubMed PMID: 11776693.

15: Kessel D. Hematoporphyrin and HPD: photophysics, photochemistry and phototherapy. Photochem Photobiol. 1984 Jun;39(6):851-9. Review. PubMed PMID: 6235529.

16: Pan QQ, Ha XW. Photodynamic effect of hematoporphyrin derivative (HpD) on normal and malignant cells in vitro. Proc Chin Acad Med Sci Peking Union Med Coll. 1987;2(2):55-8. Review. PubMed PMID: 3321050.

17: Steele JK, Liu D, Stammers AT, Deal H, Whitney S, Levy JG. Suppressor deletion therapy. Selective elimination of T suppressor cells using a hematoporphyrin-conjugated monoclonal antibody. Targeted Diagn Ther. 1988;1:157-89. Review. PubMed PMID: 2980947.

18: Benson RC Jr. Endoscopic management of bladder cancer with hematoporphyrin derivative phototherapy. Urol Clin North Am. 1984 Nov;11(4):637-42. Review. PubMed PMID: 6390913.

19: Nieva J, Wentworth P Jr. The antibody-catalyzed water oxidation pathway--a new chemical arm to immune defense? Trends Biochem Sci. 2004 May;29(5):274-8. Review. PubMed PMID: 15130564.

20: Moor AC. Signaling pathways in cell death and survival after photodynamic therapy. J Photochem Photobiol B. 2000 Aug;57(1):1-13. Review. PubMed PMID: 11100832.